These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1189 related articles for article (PubMed ID: 23496208)

  • 21. Blocking farnesylation of the prelamin A variant in Hutchinson-Gilford progeria syndrome alters the distribution of A-type lamins.
    Wang Y; Ostlund C; Choi JC; Swayne TC; Gundersen GG; Worman HJ
    Nucleus; 2012; 3(5):452-62. PubMed ID: 22895092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.
    Pellegrini C; Columbaro M; Capanni C; D'Apice MR; Cavallo C; Murdocca M; Lattanzi G; Squarzoni S
    Oncotarget; 2015 Oct; 6(30):29914-28. PubMed ID: 26359359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations.
    Gonzalo S; Kreienkamp R; Askjaer P
    Ageing Res Rev; 2017 Jan; 33():18-29. PubMed ID: 27374873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells.
    Cao K; Graziotto JJ; Blair CD; Mazzulli JR; Erdos MR; Krainc D; Collins FS
    Sci Transl Med; 2011 Jun; 3(89):89ra58. PubMed ID: 21715679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hutchinson-Gilford progeria syndrome.
    Pollex RL; Hegele RA
    Clin Genet; 2004 Nov; 66(5):375-81. PubMed ID: 15479179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome.
    Liu GH; Barkho BZ; Ruiz S; Diep D; Qu J; Yang SL; Panopoulos AD; Suzuki K; Kurian L; Walsh C; Thompson J; Boue S; Fung HL; Sancho-Martinez I; Zhang K; Yates J; Izpisua Belmonte JC
    Nature; 2011 Apr; 472(7342):221-5. PubMed ID: 21346760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of lamin A- and progerin-interacting genome regions.
    Kubben N; Adriaens M; Meuleman W; Voncken JW; van Steensel B; Misteli T
    Chromosoma; 2012 Oct; 121(5):447-64. PubMed ID: 22610065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a Drosophila model of Hutchinson-Gilford progeria syndrome.
    Beard GS; Bridger JM; Kill IR; Tree DR
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1389-92. PubMed ID: 19021561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts.
    Eisch V; Lu X; Gabriel D; Djabali K
    Oncotarget; 2016 Apr; 7(17):24700-18. PubMed ID: 27015553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53.
    Kudlow BA; Stanfel MN; Burtner CR; Johnston ED; Kennedy BK
    Mol Biol Cell; 2008 Dec; 19(12):5238-48. PubMed ID: 18843043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A-type lamins and Hutchinson-Gilford progeria syndrome: pathogenesis and therapy.
    Gonzalez JM; Pla D; Perez-Sala D; Andres V
    Front Biosci (Schol Ed); 2011 Jun; 3(3):1133-46. PubMed ID: 21622261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphibian oocyte nuclei expressing lamin A with the progeria mutation E145K exhibit an increased elastic modulus.
    Kaufmann A; Heinemann F; Radmacher M; Stick R
    Nucleus; 2011; 2(4):310-9. PubMed ID: 21941106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of progerin-interactive partner proteins with lamina proteins: Mel18 is associated with emerin in HGPS.
    Ju WN; Brown WT; Zhong N
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 41(4):397-401. PubMed ID: 19727227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.
    Scaffidi P; Misteli T
    Nat Med; 2005 Apr; 11(4):440-5. PubMed ID: 15750600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
    Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.
    Yang SH; Bergo MO; Toth JI; Qiao X; Hu Y; Sandoval S; Meta M; Bendale P; Gelb MH; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10291-6. PubMed ID: 16014412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence.
    Benson EK; Lee SW; Aaronson SA
    J Cell Sci; 2010 Aug; 123(Pt 15):2605-12. PubMed ID: 20605919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of aging, progeria and lamin disorders.
    Ghosh S; Zhou Z
    Curr Opin Genet Dev; 2014 Jun; 26():41-6. PubMed ID: 25005744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hutchinson-Gilford Progeria Syndrome: Challenges at Bench and Bedside.
    Kreienkamp R; Gonzalo S
    Subcell Biochem; 2019; 91():435-451. PubMed ID: 30888661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasticity of the nuclear envelope and hypermobility of telomeres due to the loss of A-type lamins.
    De Vos WH; Houben F; Hoebe RA; Hennekam R; van Engelen B; Manders EM; Ramaekers FC; Broers JL; Van Oostveldt P
    Biochim Biophys Acta; 2010 Apr; 1800(4):448-58. PubMed ID: 20079404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.